Cardinal Health experts recommend that CGT manufacturers design a comprehensive market access strategy early in clinical development, ideally more than three years prior to launch. This strategy should focus on addressing the nuanced market access challenges for treatments, including but not limited to, distribution network design, tailored commercial site engagement and early payer communication planning.
Our new article dives deeper into these key market access challenges and reviews mitigation strategies.